-
1
An integrated machine learning approach delineates an entropic expansion mechanism for the binding of a small molecule to α-synuclein
Published 2024-12-01Subjects: “…alpha synuclein…”
Get full text
Article -
2
Targeting the gut to protect from ascending pathology in the paraquat and lectin model of Parkinson's disease
Published 2024-11-01Subjects: Get full text
Article -
3
Exploring the Potential of Biomimetic Peptides in Targeting Fibrillar and Filamentous Alpha-Synuclein—An In Silico and Experimental Approach to Parkinson’s Disease
Published 2024-11-01Subjects: “…alpha-synuclein…”
Get full text
Article -
4
Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles
Published 2024-11-01Subjects: “…Alpha-synuclein…”
Get full text
Article -
5
N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
Published 2024-12-01Subjects: “…alpha-synuclein…”
Get full text
Article -
6
Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
Published 2025-02-01Subjects: “…Alpha-Synuclein…”
Get full text
Article -
7
Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons
Published 2024-11-01Subjects: “…alpha-synuclein…”
Get full text
Article -
8
Squalamine as a Potential Neuroprotective Agent in Parkinson's Disease Related Cognitive Decline
Published 2024-11-01Subjects: Get full text
Article -
9
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
Published 2025-01-01Subjects: Get full text
Article -
10
Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic Drosophila melanogaster models
Published 2024-12-01Subjects: “…Alpha-synuclein…”
Get full text
Article -
11
Prion meeting 2023: implications of a growing field
Published 2024-12-01Subjects: “…Alpha-synuclein…”
Get full text
Article -
12
Novel approaches targeting α-Synuclein for Parkinson's Disease: Current progress and future directions for the disease-modifying therapies
Published 2024-12-01Subjects: Get full text
Article -
13
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
Published 2022-01-01Subjects: Get full text
Article -
14
Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein
Published 2024-11-01Subjects: Get full text
Article -
15
Substantia nigra alterations in mice modeling Parkinson’s disease
Published 2024-11-01Subjects: Get full text
Article -
16
A review of gut microbiota as a therapeutic approach for Parkinson’s disease
Published 2024-12-01Subjects: “…alpha-synuclein…”
Get full text
Article -
17
NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson’s model
Published 2025-01-01Subjects: Get full text
Article -
18
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
Published 2024-12-01Subjects: Get full text
Article -
19
Bacterial products initiation of alpha-synuclein pathology: an in vitro study
Published 2024-12-01Subjects: Get full text
Article -
20
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Published 2025-02-01Subjects: Get full text
Article